DDW Highlights: 23 December 2024
The Drug Discovery World Podcast
Advancements in Cancer Treatment and Corporate Milestones
This chapter explores recent breakthroughs in genetic medicine focused on treating Sickle Cell Disease, including Otomo Pharma's successful Series A funding of over $140 million. It also highlights the development of Jankis Tomek, a new bifunctional antibody for cancer therapy, and the company's strategic objectives in the oncology sector.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
